ಟ್ವೀಟ್ಗಳು
- ಟ್ವೀಟ್ಗಳು
- ಟ್ವೀಟ್ಗಳು & ಪ್ರತಿಕ್ರಿಯೆಗಳು
- ಮಾಧ್ಯಮ
@CircAHA ತಡೆಹಿಡಿಯಲಾಗಿದೆ
ನೀವು ಖಚಿತವಾಗಿಯೂ ಈ ಟ್ವೀಟ್ಗಳನ್ನು ನೋಡಲು ಬಯಸುವಿರಾ? ಟ್ವೀಟ್ಗಳನ್ನು ನೋಡುವುದು @CircAHA ಅವರನ್ನು ತಡೆತೆರವುಗೊಳಿಸುವುದಿಲ್ಲ.
-
#Editorial by@DLBHATTMD:#PIONEERs - The Beginning of the End of Full Dose Triple Therapy with Warfarin? https://goo.gl/cVfLWJ pic.twitter.com/X7dQqOSWwB
-
Evolocumab & atorvastatin indep ⇧ VLDL, IDL, LDL catab. PCSK9 inh ⇩ LDL, IDL prod https://goo.gl/ukJosS pic.twitter.com/EstLp4F5uf
-
#Podcast Drs. Gibson and Bhatt Discuss PIONEER https://goo.gl/bZNQjB pic.twitter.com/oHNbrcySUB
-
#Perspective: Commonalities between vasculature and bone: an osseocentric view of arteriosclerosis https://goo.gl/m94sIL pic.twitter.com/Zzk8g5Zjbs
-
#Editorial: Understanding the impact of PCSK9 inhibitors on ApoB metabolism https://goo.gl/pxd2es -
#PCSK9 inhibition increases efficiency of#LDL removal and reduces LDL-ApoB production https://goo.gl/zKMXGc pic.twitter.com/d8tzqJog2f
-
#PIONEER: ⇩ Hospitalzn & mortality w/ Rivaroxaban + P2Y12 inh/DAPT compared to VKA + DAPT@CMichaelGibson https://goo.gl/jyD7Ix pic.twitter.com/UZuTlipuQP
-
Prophylactic LAA closure during cardiac sx assoc w/ incr post-op Afib & unchanged stroke/survival rate https://goo.gl/LDCmrc pic.twitter.com/tLSjjPCv54
-
The XY sex chromosome influences aortic gene expression and promotes
#AAA severity https://goo.gl/YTGwIe pic.twitter.com/eGfP5kJIQb
-
#CHANCE trial: Effect of ASA+Clopidogrel in Sec Stroke prev varies by smoking status https://goo.gl/g4VA2L pic.twitter.com/mwlrylJcko
-
A majority of older adults in the Atherosclerosis Risk in Communites Study are at risk for heart failure https://goo.gl/KkYNcW pic.twitter.com/iDXg4D95pp
-
#Editorial: Adding rigor to stroke rate assessment in#Afib https://goo.gl/01xtP3 -
Lp(a) and OxPL-apoB are predictors of
#MACE across ethnic groups https://goo.gl/GnB7cP pic.twitter.com/DmaRE7c4FU
-
#Podcast D. Singer: Variation in Atrial Fibrillation Stroke Rates https://goo.gl/CnMgcq -
#EUCLID: PAD w/ prior revasc - no diff in CV events w/ Ticagrelor vs Clopidogrel https://goo.gl/7VNUww pic.twitter.com/fBs3oh5xDA
-
.
@CircOutcomes in good hands w/new Editorial team, led by@bnallamo. Nice welcome editorial…New Beginnings.@CircAHA http://circoutcomes.ahajournals.org/content/10/1/e003512?etoc= …pic.twitter.com/UdQ0Z1QHRc
-
Adding RVEF to LVEF improves risk prediction for Sudden Death / ICD events.
@CircAHA@SCMRorg@mariavandenbosc http://circep.ahajournals.org/content/10/1/e004067.full?ijkey=cTyRYsTLMznNMrC&keytype=ref …pic.twitter.com/XcqzKdBNo3
-
Deputy editor Mike Ho (
@mho_md) introduces the Evaluating Value Series https://goo.gl/Zu9Nup pic.twitter.com/YEq8YtdnTl
-
Editor's perspective by Brahmajee Nallamothu (
@bnallamo) introduces 3 new article series and other new initiatives https://goo.gl/ufu2Vg pic.twitter.com/fTpWOuBpCQ
-
Endothelial microparticles from
#ACS pts induce endothelial dysfunction https://goo.gl/EStWLF pic.twitter.com/KIEIjeDW8V
ಲೋಡಿಂಗ್ ಸಮಯ ಸ್ವಲ್ಪ ತೆಗೆದುಕೊಳ್ಳುತ್ತಿರುವಂತೆನಿಸುತ್ತದೆ.
Twitter ಸಾಮರ್ಥ್ಯ ಮೀರಿರಬಹುದು ಅಥವಾ ಕ್ಷಣಿಕವಾದ ತೊಂದರೆಯನ್ನು ಅನುಭವಿಸುತ್ತಿರಬಹುದು. ಮತ್ತೆ ಪ್ರಯತ್ನಿಸಿ ಅಥವಾ ಹೆಚ್ಚಿನ ಮಾಹಿತಿಗೆ Twitter ಸ್ಥಿತಿಗೆ ಭೇಟಿ ನೀಡಿ.
Circulation
Harlan Krumholz
James White
Circulation: CVQO